Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
Not Applicable
Completed
- Conditions
- HIV Infections
- Registration Number
- NCT00002051
- Lead Sponsor
- Immunobiology Research Institute
- Brief Summary
Examine the ability of thymopentin (Timunox) to:
Reduce the amount and/or frequency of virus isolation. Stimulate the immune system and alter the clinical findings in patients infected with HIV who do not yet have AIDS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Immunobiology Research Institute
🇺🇸Annandale, New Jersey, United States
Immunobiology Research Institute🇺🇸Annandale, New Jersey, United States